Santen Pharmaceutical Co.... (SNPHF)

PNK: SNPHF · Real-Time Price · USD

9.80

-2.66 (-21.35%)

At close: Apr 29, 2025, 3:09 PM

Santen Pharmaceutical Income Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015
Revenue	304.35B	301.96B	302.08B	295.93B	285.89B	279.04B	270.24B	266.41B	266.8B	266.26B	263.62B	259.46B	257.03B	249.6B	241.01B	241.69B	239.98B	241.56B	243.14B	238.46B	236.68B	234.03B	229.56B	228.51B	225.48B	224.94B	217.02B	212.04B	205.04B	199.09B	196.75B	195.25B	197.32B	195.29B	194.19B	187.78B	176.12B
Cost of Revenue	127.63B	125.64B	119.1B	116.5B	114.57B	112.95B	112.42B	112.71B	111.15B	109.67B	105.03B	101.38B	100.4B	98.22B	96.37B	96.23B	95.45B	94.83B	95.31B	93.29B	91.86B	90.76B	90.04B	89.18B	87.82B	86.38B	83.48B	81.1B	78.15B	74.97B	73.73B	73.16B	73.36B	72.83B	71.63B	66.28B	60.66B
Gross Profit	176.72B	176.32B	182.98B	179.42B	171.32B	166.09B	157.82B	153.71B	155.65B	156.59B	158.59B	158.08B	156.62B	151.38B	144.64B	145.45B	144.53B	146.72B	147.83B	145.16B	144.82B	143.26B	139.52B	139.33B	137.66B	138.56B	133.54B	130.94B	126.89B	124.13B	123.02B	122.08B	123.97B	122.46B	122.56B	121.5B	115.47B
Operating Income	47.66B	47.26B	43.22B	41.03B	1.33B	-3.09B	-641M	-1.94B	35.06B	36.27B	12.41B	13.42B	14.44B	12.92B	31.86B	33.21B	32.31B	33.54B	40.38B	43.28B	44.33B	45.1B	42.26B	38.48B	36.65B	38.69B	35.08B	34.73B	33.72B	32.48B	33.25B	33.58B	80.19B	80.18B	85.46B	87.56B	40.78B
Interest Income	1.6B	1.95B	1.85B	1.79B	1.76B	2.1B	3.27B	3.38B	3.34B	2.54B	1.54B	1.45B	1.41B	1.34B	1.09B	1.27B	1.31B	1.22B	1.18B	872M	842M	901M	2.29B	2.29B	2.29B	2.24B	2.37B	3.13B	3.1B	3.08B	1.54B	777M	783M	819M	1.51B	1.22B	1.21B
Pretax Income	35.1B	34.52B	39.35B	37.38B	-2B	-5.8B	-1.65B	-1.88B	35.52B	36B	11.51B	12.84B	13.61B	12.42B	30.09B	32.04B	31.45B	32.09B	39.68B	41.73B	42.66B	43.12B	42.13B	38.37B	36.63B	39.39B	34.7B	35.61B	33.78B	31.82B	31.8B	31.16B	78.5B	79.47B	85.48B	87.54B	41.59B
Net Income	26.86B	26.64B	27.73B	26.37B	-11.21B	-14.96B	-8.15B	-9.09B	26.55B	27.23B	5.2B	7.28B	7.93B	6.78B	24.23B	24.25B	23.42B	23.63B	28.86B	30.7B	31.49B	31.94B	31.28B	34.39B	33.1B	35.26B	30.59B	25.7B	24.65B	22.96B	23.2B	22.22B	53.16B	53.37B	57.73B	59B	28.58B
Selling & General & Admin	91.84B	91.53B	95.5B	97.14B	97.89B	96.26B	89.68B	87.14B	83.48B	84.5B	87.06B	85.96B	84.45B	79.55B	73.35B	73.18B	72.86B	73.36B	72.88B	71.22B	71.15B	71.27B	70.51B	70.59B	69.91B	68.79B	67.11B	65.13B	63.15B	62.19B	60.92B	60.56B	60.19B	59.41B	46.03B	43.23B	40.64B
Research & Development	24.62B	25.41B	24.82B	26.49B	27.5B	28.3B	29.26B	28.3B	27.36B	26.38B	25.26B	25.33B	24.62B	24.11B	23.84B	23.05B	22.78B	23.34B	23.82B	24.21B	24.32B	23.76B	23.59B	23.62B	24.41B	24.4B	24.75B	24.22B	23.24B	22.79B	21.64B	21.05B	20.56B	19.99B	31.76B	31.02B	30.46B
Other Expenses	2.73B	n/a	n/a	n/a	n/a	2.27B	4.5B	6.99B	9.75B	9.44B	33.87B	33.37B	33.12B	34.8B	15.6B	16.01B	16.58B	16.49B	10.74B	6.45B	5.03B	3.13B	3.16B	6.65B	6.7B	6.69B	6.59B	6.85B	6.77B	6.67B	7.22B	6.89B	-36.98B	-37.11B	-20.25B	-21.64B	20.68B
Operating Expenses	129.06B	129.06B	139.77B	138.39B	170B	169.18B	158.47B	155.65B	120.58B	120.32B	146.18B	144.66B	142.19B	138.47B	112.78B	112.24B	112.22B	113.19B	107.45B	101.88B	100.49B	98.16B	97.26B	100.86B	101.01B	99.87B	98.46B	96.21B	93.16B	91.65B	89.78B	88.5B	43.77B	42.28B	37.1B	33.93B	74.69B
Interest Expense	3.28B	3.04B	2.15B	2.57B	2.49B	2.45B	2.13B	1.3B	1.05B	1.21B	1.07B	1.04B	1.58B	1.49B	2.69B	2.69B	2.43B	2.93B	2.15B	2.42B	2.5B	2.88B	2.12B	2.09B	1.99B	1.23B	1.23B	737M	1.53B	2.22B	2.99B	3.2B	2.48B	1.53B	977M	782M	313M
Selling & Marketing Expenses	21.48B	21.48B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	15.95B	15.95B	15.95B	15.95B	15.24B	15.24B	15.24B	15.24B	12.22B	12.22B	12.22B
Cost & Expenses	256.68B	254.71B	258.87B	254.9B	284.57B	282.13B	270.88B	268.35B	231.74B	229.99B	251.21B	246.04B	242.59B	236.69B	209.16B	208.48B	207.68B	208.02B	202.76B	195.17B	192.35B	188.93B	187.3B	190.04B	188.83B	186.25B	181.94B	177.31B	171.31B	166.62B	163.51B	161.66B	117.13B	115.11B	108.74B	100.21B	135.34B
Income Tax Expense	3.56B	3.17B	11.67B	11.07B	9.26B	9.18B	6.54B	7.21B	8.96B	8.77B	6.47B	5.6B	5.72B	5.77B	7.71B	9.75B	10B	10.38B	10.82B	11.04B	11.18B	11.18B	10.85B	3.97B	3.53B	4.22B	4.21B	10.01B	9.13B	8.77B	8.5B	8.84B	25.34B	26.1B	27.76B	28.95B	13.75B
Shares Outstanding (Basic)	360.44M	363.21M	353.63M	360.45M	372.78M	377.03M	385.52M	379.87M	396.75M	400.27M	399.76M	399.73M	399.89M	399.45M	399.45M	399.42M	399.37M	399.13M	399.13M	399.12M	399.1M	407.02M	407.02M	406.99M	406.88M	406.44M	406.44M	406.29M	406.18M	407.23M	407.23M	413.76M	414.19M	413.85M	413.85M	413.77M	413.42M
Shares Outstanding (Diluted)	360.44M	363.21M	354.92M	361.6M	373.98M	377.03M	386.55M	379.87M	397.31M	400.51M	400.54M	400.48M	400.33M	399.45M	400.43M	400.42M	400.36M	399.13M	400.38M	400.31M	400.21M	407.02M	408.32M	408.21M	408.13M	406.44M	407.97M	407.79M	407.65M	407.23M	408.78M	415.28M	415.76M	413.85M	415.74M	415.62M	415.44M
EPS (Basic)	74.91	73.34	76.22	70.98	-29.21	-40.35	-23.52	-26.41	66.61	68.28	13.15	18.53	20.19	17.22	60.93	60.87	58.69	59.23	71.93	76.11	77.69	78.51	76.91	84.52	81.39	86.74	75.23	63.23	60.39	55.87	56.33	53.67	128.43	128.99	139.54	142.66	69.17
EPS (Diluted)	74.76	73.11	75.99	70.79	-29.32	-40.4	-23.58	-26.45	66.53	68.20	13.08	18.43	20.08	17.10	60.81	60.73	58.55	59.08	71.78	75.95	77.53	78.33	76.73	84.30	81.16	86.49	74.98	63.02	60.20	55.69	56.15	53.50	127.92	128.46	139.01	142.10	68.93
EBITDA	66.52B	65.44B	99.33B	96.58B	56.11B	52.13B	16.59B	15.41B	52.77B	52.93B	29.09B	30.36B	30.96B	30.12B	55.1B	56.09B	55.2B	56.43B	51.77B	53.24B	52.96B	52.36B	53.4B	49.61B	47.74B	49.7B	46.16B	45.58B	44.3B	42.79B	-822M	-602M	45.9B	45.67B	93.75B	95.78B	48.81B
EBIT	51.06B	50.94B	41.5B	39.95B	486M	-3.35B	481M	-580M	36.84B	36.8B	12.18B	13.11B	14.15B	13.54B	32.41B	33.83B	32.99B	34.13B	40.94B	44.16B	45.17B	46B	43.32B	39.53B	37.7B	39.7B	35.92B	35.69B	34.66B	33.39B	34.14B	34.36B	80.97B	81B	86.46B	88.24B	41.42B
Depreciation & Amortization	18.85B	18.18B	17.72B	17.16B	16.81B	17.25B	17.66B	17.77B	17.71B	17.05B	16.92B	17.25B	16.83B	17.13B	16.98B	16.55B	16.57B	16.57B	15.09B	13.66B	12.34B	10.97B	11.03B	11.02B	10.98B	10.9B	10.66B	10.43B	10.15B	9.88B	9.78B	9.66B	9.56B	9.34B	8.38B	8.31B	8.14B